(redirected from Fibromyalgia Impact Questionnaire)
Also found in: Medical.
FIQFrequently Ignored Question
FIQFinal Delivered Image Quality
FIQFibromyalgia Impact Questionnaire
FIQFédération Interprofessionnelle de La Santé du Québec (French: Interprofessional Federation of the Health of Québec; Canada)
FIQFast Interrupt Request
FIQFédération Internationale des Quilleurs
FIQFonds d'Intervention de Quartier (French: District Intervention Fund)
FIQFinancial Information Questionnaire
FIQFederation d'Informatique Du Quebec
FIQFellow of the Institute of Quarrying
FIQFinancial Intelligence Quotient
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12.
Conclusion: We conclude that the hematological indices are significantly altered and they are significantly correlated with the total score of fibromyalgia impact questionnaire revised.
The mean score of the fibromyalgia impact questionnaire was 53.3+-15.3 and 125(91.9%) patients had a mild level.
A Brazilian Portuguese version of the Revised Fibromyalgia Impact Questionnaire (FIQR): a validation study.
Criterion validity of FPQ-T (Turkish version of the Fibromyalgia Participation Questionnaire) against the FIQ (Fibromyalgia Impact Questionnaire) FPQ-T Daily life Social life Work life Daily + social life Overall FIQ r 0.576 0.531 0.452 0.582 0.558 p <0.001 <0.001 <0.001 <0.001 <0.001 FPQ-T: Turkish version of the Fibromyalgia Participation Questionnaire; FIQ: Fibromyalgia Impact Questionnaire Table 5.
EngstromLaurent, "The fibromyalgia impact questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient," Scandinavian Journal of Rheumatology, vol.
Bennett, "The fibromyalgia impact questionnaire: development and validation," Journal of Rheumatology, vol.
Relationship between the Fibromyalgia Impact Questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study.
Minimal clinically important difference in the fibromyalgia impact questionnaire. Journal of Rheumatology, 36, 1304-1311.
CoQ10 treatment resulted in significant improvements in the biochemical markers, a 35% decrease in the mean number of tender points (p 0.001), a 39% improvement in the Headache Impact Test-6 score (p 0.001), and a 49% improvement in the Fibromyalgia Impact Questionnaire score (p 0.001).
Weekly Fibromyalgia Impact Questionnaire (FIQ) was administered verbally and recorded.
The sixth outcome measure was change in the impact of fibromyalgia on daily life, as assessed by the 10-item Fibromyalgia Impact Questionnaire (FIQ).